SEngine Precision Medicine aims to raise $40M in Series B
August 17, 2020 at 04:20 AM EDT
SEngine takes biopsies of tumors and grows them outside the body, a process the company is attempting to automate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|